论文部分内容阅读
Renvela关键词:获得正面评价Genzyme公司日前宣布,EMEA人用药委员会(CHMP)对该公司用于慢性肾病(CKD)患者的磷酸盐结合剂Renvela(sevelamer carbonate碳酸司
Renvela Keywords: Get a Positive Comment Genzyme Inc. announced that the EMEA Human Pharmaceutical Committee (CHMP) has tested the company’s phosphate binder Renvela (sevelamer carbonate) for patients with chronic kidney disease (CKD)